Search
Tag: Biomea Fusion
Biomea Fusion Shares Dive Following Public Offering Announcement
Biomea Fusion shares plunged nearly 34% as investors reacted to a $25M stock offering, offsetting optimism from recent positive diabetes…
Biomea’s Icovamenib Drug Shows Potential for Diabetes Patients
Biomea’s icovamenib shows lasting blood sugar reduction in type 2 diabetes, offering new hope for patients unresponsive to GLP-1 treatments.
Biomea Fusion Launches Public Offering of Shares and Warrants
Biomea Fusion launches a public stock and warrant offering to fund its ongoing work in diabetes and obesity therapies amid…